Aclaris Therapeutics (ACRS) Goodwill & Intangibles (2017 - 2023)

Aclaris Therapeutics has reported Goodwill & Intangibles for 7 years, with the latest figure at $269000.0 in Q4 2023.

• For the quarter ending Q4 2023, Goodwill & Intangibles fell 96.36% year-over-year to $269000.0; the trailing twelve-month figure through Dec 2023 stood at $269000.0 (down 96.36% YoY), and the FY2023 full-year result was $269000.0, down 96.36% from the prior year.
• Goodwill & Intangibles for Q4 2023 stood at $269000.0, down from $6.9 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $92.3 million in Q1 2019, with the low at $269000.0 in Q4 2023.
• Average Goodwill & Intangibles over 5 years is $15.0 million, with a median of $7.1 million recorded in 2020.
• Year-over-year, Goodwill & Intangibles sank 97.09% in 2019 and surged 851.0% in 2020.
• Tracing ACRS's Goodwill & Intangibles over 5 years: stood at $25.9 million in 2019, then plunged by 72.48% to $7.1 million in 2020, then grew by 3.61% to $7.4 million in 2021, then changed by 0.0% to $7.4 million in 2022, then sank by 96.36% to $269000.0 in 2023.
• The last three Goodwill & Intangibles figures came in at $269000.0 (Q4 2023), $6.9 million (Q3 2023), and $6.9 million (Q2 2023), per Business Quant data.

Peer Comparison